Results 11 to 20 of about 490,369 (261)

SARS‐CoV‐2 and hypertension [PDF]

open access: yesPhysiological Reports, 2021
The objective of this review is to give an overview of the pathophysiological effects of the Coronavirus Disease 2019 (COVID‐19) in relation to hypertension (HT), with a focus on the Renin–Angiotensin–Aldosterone System (RAAS) and the MAS receptor. HT is
Briyanth Ravichandran   +5 more
doaj   +4 more sources

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2 [PDF]

open access: yesAdvanced Science, 2020
The world is currently experiencing a global pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes severe respiratory disease similar to SARS.
Yetian Dong   +4 more
doaj   +3 more sources

Peptide‐Based Inhibitors for SARS‐CoV‐2 and SARS‐CoV [PDF]

open access: yesAdvanced Therapeutics, 2021
AbstractThe COVID‐19 (coronavirus disease) global pandemic, caused by the spread of the SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) virus, currently has limited treatment options which include vaccines, anti‐virals, and repurposed therapeutics. With their high specificity, tunability, and biocompatibility, small molecules like peptides
Disha Panchal   +11 more
openaire   +2 more sources

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics [PDF]

open access: yesThe Lancet Infectious Diseases, 2020
The objective of this Personal View is to compare transmissibility, hospitalisation, and mortality rates for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with those of other epidemic coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV), and pandemic ...
Petersen E.   +8 more
openaire   +3 more sources

Crucial contribution of the universities to SARS-CoV-2 surveillance in Ecuador: Lessons for developing countries

open access: yesOne Health, 2021
COVID-19 pandemic has challenged public health systems worldwide, particularly affecting developing countries in Latin America like Ecuador. In this report, we exposed the fundamental role of the Ecuadorian universities to improve COVID-19 surveillance ...
Daniela Santander-Gordon   +19 more
doaj   +1 more source

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes

open access: yesNature Communications, 2023
Abstract The phenomenon of protein aggregation is associated with a wide range of human diseases. Our knowledge of the aggregation behaviour of viral proteins, however, is still rather limited. Here, we investigated this behaviour in the SARS-CoV and SARS-CoV-2 proteomes.
Taniya Bhardwaj   +14 more
openaire   +4 more sources

Structure and Function of Major SARS-CoV-2 and SARS-CoV Proteins [PDF]

open access: yesBioinformatics and Biology Insights, 2021
SARS-CoV-2 virus, the causative agent of COVID-19 pandemic, has a genomic organization consisting of 16 nonstructural proteins (nsps), 4 structural proteins, and 9 accessory proteins. Relative of SARS-CoV-2, SARS-CoV, has genomic organization, which is very similar.
Ritesh Gorkhali   +5 more
openaire   +3 more sources

Epidemiology of SARS-CoV-2 [PDF]

open access: yesInfection, 2020
Abstract Purpose SARS-CoV-2 is a recently emerged ß-coronavirus. Here we present the current knowledge on its epidemiologic features. Methods Non-systematic review.
Salzberger, Bernd   +7 more
openaire   +2 more sources

AmpliCoV: Rapid Whole-Genome Sequencing Using Multiplex PCR Amplification and Real-Time Oxford Nanopore MinION Sequencing Enables Rapid Variant Identification of SARS-CoV-2

open access: yesFrontiers in Microbiology, 2021
Since the emergence of the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) in December 2019, the scientific community has been sharing data on epidemiology, diagnostic methods, and whole-genomic sequences almost in real time. The latter have
Annika Brinkmann   +9 more
doaj   +1 more source

SARS-CoV-2 in silico binding affinity to human leukocyte antigen (HLA) Class II molecules predicts vaccine effectiveness across variants of concern (VOC)

open access: yesScientific Reports, 2022
There is widespread concern about the clinical effectiveness of current vaccines in preventing Covid-19 caused by SARS-CoV-2 Variants of Concern (Williams in Lancet Respir Med 29:333–335, 2021; Hayawi in Vaccines 9:1305, 2021), including those identified
Spyros A. Charonis   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy